I see two different trading options.
The more knowledge a trader holds, the higher the probability of success. Let's use Vaxart as an example.
I would be nervous if I held Apple and Tesla.
Let's review some names like TSLA, WIMI and NEXCF, and then eye a play for special purpose acquisition company Churchill Capital Corp III.
There's a good chance for volatility to rally next week.
The price action here appears to be signaling the market sees that better things are yet to come.
I think we are going to see a day or week when a lot of money comes out of AAPL in a short period of time; here's how I'd play it now.
PD has the setup for a breakout move, but we don't have the triggers just yet.
Let's use what after-hours and pre-market traders see to our advantage, using BlueCity Holdings as an example.
The firm easily outperformed expected comparable sales for the month of June.
All the current indicators from trend to momentum to price action sit in a bullish position as the stock breaks above resistance.
Here's a better way to play things.
We have multiple bullish divergences to justify a buy.
If you are confused about what to do with prices above $1,800, you aren't alone.
It's alarming how cheap the bank stocks have become.
The daily picture has my attention. The big watch here is the 50-day simple moving average.
An investor's job -- long or short -- is to take the opposite side of a position, and here's why we should take a critical look at this electric vehicle company.
The market has a love/hate relationship with TWTR.
The potential for a short squeeze remains in play as well.
Here's a call-spread idea for Virgin Galactic.
AAL has been hit hard by the coronavirus pandemic, but there's a shot at turning quickly.
Imagine what the stock market might do if the currency headwinds became tailwinds.
These XLI calls are cheap right now.
Here I'll explore ways to play this 'blank check' M&A-related company that joined with Ittella International this month to form plant-based food company Tattooed Chef.
I'd position any bearish call spread to expire before the company reports near the end of July.
The Internet security firm and gene therapy company are on my shopping list as equities continue their recent roller coaster ride.
This one feels almost too easy in terms of short-term trades.
But I like the opportunity for a speculative long as well as a nice balance against other positions that could drop if Covid increases.
The initial target here is $16 with a secondary target of $17.50 on this breakout, with a time frame of a month or less.
Would I buy the name on this dip? Not yet. But here's what a trader could do.